CHICAGO, IL — May 6, 2026 — Leads & Copy —
Cosmos Health Inc. (NASDAQ:COSM) has launched Fort18™ in the United States, a men’s sexual stamina supplement formulated with a proprietary blend of botanical extracts and nutrients evaluated in clinical research.
Fort18™ is the newest addition to the Company’s “18 Series” and enters a growing market with a science-backed formulation supported by human clinical data. Many men experience reduced sexual stamina and endurance and are seeking solutions supported by clinical research.
Clinical research on the active ingredient (Journal of Medicinal Food, September 2020) reported a 5.1-fold improvement in endurance over the placebo group over eight weeks, with results observed as early as Week 4 of the study. The randomized, double-blind, placebo-controlled study included 60 healthy men, aged 18-60, experiencing reduced sexual stamina.
Fort18™ contains a blend of five botanical extracts and nutrients: L-arginine, mucuna, fenugreek, ashwagandha, and artichoke, standardized to a minimum of 20% saponins and 1.5% total flavonoids. The formulation supports the hormonal, neuronal, and vascular pathways associated with male sexual stamina and endurance, drawing on botanical ingredients with a history of use in Ayurveda and Traditional Chinese Medicine.
Each ingredient plays a role:
- Artichoke leaf extract supports healthy blood flow through nitric oxide-related pathways.
- Fenugreek seed extract is associated with support of arousal, energy, and stamina.
- Ashwagandha root extract is an adaptogenic botanical supporting a healthy stress response and nervous system function.
- Mucuna seed extract is studied for its support of dopamine-related pathways and male wellness.
- L-Arginine is an amino acid associated with vascular support and healthy blood flow through nitric oxide production.
The formulation’s standardization fingerprint is exclusive and patent-protected. Fort18™ is formulated at 500mg twice per day, consistent with the dose evaluated in clinical research.
According to Grand View Research, the global sexual health supplement market was estimated at $3.52 billion in 2023 and is projected to reach $7.02 billion by 2030, growing at a CAGR of 10.4%. The United States is one of the largest markets, accounting for an estimated 27.4% of the global market, estimated at $965.8 million in 2023 and projected to reach $1.93 billion by 2030. Male consumers represent more than 55% of the global consumer base for sexual health supplements, per Market.us.
Cosmos Health CEO Greg Siokas said that the men’s wellness category represents a growing market opportunity where consumers are seeking products with scientific substantiation. He added that the introduction of Fort18™ is an important step in expanding the 18 Series into the United States and believes it can be a meaningful contributor to their nutraceutical portfolio.
The 18 Series includes science-based nutraceutical products designed to meet three criteria: a proprietary ingredient backed by published research, clinical studies supporting its intended use, and dosing consistent with published clinical research. In addition to Fort18™, other 18 Series products include Noor18™ (marine collagen, anti-aging), Liv18™ (liver fat support), and Cur18™ (next-generation curcumin).
Cosmos Health sources its active ingredients from established suppliers and manufactures all products in the United States under applicable quality and regulatory standards.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group with a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®.
More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.
Source: Cosmos Health Inc.
